SONA THERAPEUTICS
Sonata Therapeutics is revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact.
SONA THERAPEUTICS
Industry:
Health Care Medical Pharmaceutical
Founded:
2022-01-01
Status:
Active
Email Addresses:
[email protected]
More informations about "Sona Therapeutics"
Home Page - Sona Nanotech
Sona Nanotech developed biocompatible gold nanoparticles which it uses for the development of both cancer therapies and diagnostic testing. +1-902-442-0653 Purdy’s Wharf Tower II Suite …See details»
Sona Nanotech to Acquire Cancer Therapy Developer Siva …
Jan 26, 2023 Sona Nanotech Inc. is pleased to announce that it has entered into a binding agreement on January 26, 2023 to acquire Siva Therapeutics, Inc. +1-902-442-0653 Purdy’s …See details»
Sona Returns to its Roots - Entrevestor
Jun 4, 2023 Having raised $1.1 million by selling shares on the Canadian Securities Exchange earlier this year, Sona also grew by acquiring Boulder, Co.-based Siva Therapeutics for as much as US$8.7 million. As a merged …See details»
Sona Nanotech Inc. - LinkedIn
Sona Nanotech Inc. | 2,018 followers on LinkedIn. Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics (CSE:SONA | OTC: SNANF) | …See details»
Sona Nanotech to Acquire Cancer Therapy Developer Siva …
Jan 26, 2023 This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated …See details»
Sona Nanotech Closes Acquisition of Siva Therapeutics, Plans For …
Mar 23, 2023 This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated …See details»
Sonata Therapeutics - Crunchbase Company Profile & Funding
Sonata Therapeutics is revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based …See details»
Sona Announces Commercial Agreement with Siva Therapeutics – …
Oct 20, 2022 Sona Nanotech CEO, David Regan commented, “This agreement marks Sona’s first commercial arrangement of its gold nanorods for an emerging ‘in-vivo’ medical …See details»
Innovative Cancer Therapy Developed by Sona Nanotech | INN
Sona Nanotech's innovative cancer therapy uses gold nanorods to shrink tumors and enhance immunotherapy effectiveness, offering hope for late-stage melanoma patients.See details»
Sona Nanotech to Acquire Cancer Therapy Developer Siva …
January 26, 2023 – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company” or “Sona”) is pleased to announce that it has entered into a binding agreement (the “Definitive …See details»
Sona Nanotech Closes Acquisition of Siva Therapeutics, Plans
Mar 23, 2023 Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has closed its previously announced acquisition of Siva Therapeutics, Inc. …See details»
Sona Nanotech Receives Waiver on Requirement to Raise …
Mar 6, 2023 David Regan, CEO of Sona, commented, "The oversubscribed financing and waiver pave the way for us to complete our acquisition of Siva Therapeutics.See details»
Sona Nanotech Ltd. - Funding, Financials, Valuation & Investors
Sona Nanotech Ltd. is registered under the ticker CSE:SONA . Sona Nanotech Ltd. is funded by 6 investors. National Research Council of Canada Industrial Research Assistance Program and …See details»
Sona Nanotech Closes Acquisition of Siva Therapeutics, Plans for …
Mar 27, 2023 Sona Nanotech Inc. has announced the completion of its acquisition of Siva Therapeutics Inc. As part of the deal, Sona has issued over 15 million common shares in the …See details»
Biocompatible Nanoparticle Technology Unlocking Cancer …
Sona GNRs could unlock the power of in-vivo applications Uniquely Biocompatible: Sona surfactant uses no CTAB • Can produce heat in the same way as CTAB-based GNRs. • …See details»
sona - Crunchbase Company Profile & Funding
Sona is a digital therapeutics company, using science-backed music to improve mental health. sona produces and distributes original music made in collaboration with grammy-winning …See details»
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief …
13 hours ago Orna Therapeutics is dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA ®) therapeutics to unlock the potential of RNA medicine to …See details»
Sona Nanotech’s THT Cancer Studies Demonstrates Strong …
Dec 11, 2024 Sona Nanotech CEO, David Regan, commented, “ The further preclinical evidence presented in compelling data gives us greater confidence as to Sona’s THT’s ability to prime …See details»
Sona Nanotech's THT Cancer Studies Demonstrates Strong …
Dec 11, 2024 Sona Nanotech CEO, David Regan, commented, "The further preclinical evidence presented in compelling data gives us greater confidence as to Sona's THT's ability to prime …See details»
Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies ...
Jan 13, 2025 Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the …See details»